These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1576458)

  • 21. Cholecystokinin inhibits food intake at a peripheral extragastric site.
    Zittel TT; Elm BV; Teichmann RK; Becker HD; Raybould HE
    Ann N Y Acad Sci; 1994 Mar; 713():431-4. PubMed ID: 8185211
    [No Abstract]   [Full Text] [Related]  

  • 22. Reversal of the anorectic effect of (+)-fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK-329.
    Cooper SJ; Dourish CT; Barber DJ
    Br J Pharmacol; 1990 Jan; 99(1):65-70. PubMed ID: 2331576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluoxetine reduces food intake by a cholecystokinin-independent mechanism.
    Cooper SJ; Dourish CT; Barber DJ
    Pharmacol Biochem Behav; 1990 Jan; 35(1):51-4. PubMed ID: 2315369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous cholecystokinin is not a major regulator of food intake in the chicken.
    Choi YH; Furuse M; Satoh S; Okumura J
    J Comp Physiol B; 1994; 164(6):425-9. PubMed ID: 7860804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholecystokinin antagonist and lipid intake as a function of caloric density and familiarity.
    Deutsch JA; Chen DY; Carrera-Alberro MR
    Physiol Behav; 1992 May; 51(5):1057-60. PubMed ID: 1615044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of Cholecystokinin in Food Intake: II. Lactational Hyperphagia in the Rat.
    Lindén A; Uvnäs-Moberg K; Forsberg G; Bednar I; Enerotht P; Södersten P
    J Neuroendocrinol; 1990 Dec; 2(6):791-6. PubMed ID: 19215420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of Cholecystokinin in Food Intake: III. Oestradiol Potentiates the Inhibitory Effect of Cholecystokinin Octapeptide on Food Intake in Ovariectomized Rats.
    Lindén A; Uvnäs-Moberg K; Forsberg G; Bednar I; Södersten P
    J Neuroendocrinol; 1990 Dec; 2(6):797-801. PubMed ID: 19215421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amelioration of cholinergic-induced pancreatitis with a selective cholecystokinin receptor antagonist.
    Bilchik AJ; Zucker KA; Adrian TE; Modlin IM
    Arch Surg; 1990 Dec; 125(12):1546-9. PubMed ID: 2244806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in nutritional status associated with obstructive jaundice and biliary drainage in rats.
    Gouma DJ; Roughneen PT; Kumar S; Moody FG; Rowlands BJ
    Am J Clin Nutr; 1986 Sep; 44(3):362-9. PubMed ID: 3751957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of cholecystokinin in food intake: I. Concentrations of cholecystokinin-like immunoreactivity in the cerebrospinal fluid of male rats.
    Lindén A; Uvnäs-Moberg K; Forsbergt G; Bednar I; Södersten P
    J Neuroendocrinol; 1990 Dec; 2(6):783-9. PubMed ID: 19215419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anorexia and the effect of internal biliary drainage on food intake in patients with obstructive jaundice.
    Padillo FJ; Andicoberry B; Naranjo A; Miño G; Pera C; Sitges-Serra A
    J Am Coll Surg; 2001 May; 192(5):584-90. PubMed ID: 11333095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight.
    Kopin AS; Mathes WF; McBride EW; Nguyen M; Al-Haider W; Schmitz F; Bonner-Weir S; Kanarek R; Beinborn M
    J Clin Invest; 1999 Feb; 103(3):383-91. PubMed ID: 9927499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of cholecystokinin (CCK8) on glucose production and elimination, and on plasma insulin and glucose in rats.
    Verspohl EJ; Zoll C; Wahl MA; Ammon HP
    Peptides; 1992; 13(6):1091-5. PubMed ID: 1494491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of dopamine in inhibition of food intake by cholecystokinin octapeptide in male rats.
    Bednar I; Forsberg G; Lindén A; Qureshi GA; Södersten P
    J Neuroendocrinol; 1991 Oct; 3(5):491-6. PubMed ID: 19215497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical and experimental status of the metabolic aspects of obstructive jaundice].
    Zubkov VI; Shevchenko VM; Dubitskiĭ AE; Kuz'menko AA; Sikerina EG
    Vestn Khir Im I I Grek; 1977 Oct; 119(10):43-7. PubMed ID: 929877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weight loss and altered circulating GI peptide levels of rats exposed chronically to nicotine.
    Chowdhury P; Hosotani R; Rayford PL
    Pharmacol Biochem Behav; 1989 Jul; 33(3):591-4. PubMed ID: 2587602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of food intake and adrenergic response in rats during the tail pinch test].
    Junquera J; Moreau D; Guilland JC; Noirot P; Klepping J
    C R Seances Soc Biol Fil; 1978; 172(4):640-6. PubMed ID: 154944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A model of reversible obstructive jaundice in the rat.
    Posner MC; Burt ME; Stone MD; Han BL; Warren RS; Vydelingum NA; Brennan MF
    J Surg Res; 1990 Mar; 48(3):204-10. PubMed ID: 2314093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bilirubin metabolism in obstructive jaundice. 2. Mechanism of elevation of serum unconjugated bilirubin levels in obstructive jaundice].
    Shirachi T
    Nihon Shokakibyo Gakkai Zasshi; 1977 Mar; 74(3):275-83. PubMed ID: 558406
    [No Abstract]   [Full Text] [Related]  

  • 40. Modulation of immune function and weight loss by L-arginine in obstructive jaundice in the rat.
    Kennedy JA; Kirk SJ; McCrory DC; Halliday MI; Barclay GR; Rowlands BJ
    Br J Surg; 1994 Aug; 81(8):1199-201. PubMed ID: 7953359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.